Global Oral Vaccines Market Outlook 2022

Global Oral Vaccines Market Outlook 2022

Table of Contents
1 Oral Vaccines Market Overview
1.1 Product Overview and Scope of Oral Vaccines
1.2 Oral Vaccines Segment by Type
1.2.1 Global Oral Vaccines Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Rotavirus Vaccine
1.2.3 Cholera Vaccine
1.2.4 Oral Polio Vaccine
1.3 Oral Vaccines Segment by Application
1.3.1 Global Oral Vaccines Sales Comparison by Application: (2021-2027)
1.3.2 Public
1.3.3 Private
1.4 Global Oral Vaccines Market Size Estimates and Forecasts
1.4.1 Global Oral Vaccines Revenue 2016-2027
1.4.2 Global Oral Vaccines Sales 2016-2027
1.4.3 Oral Vaccines Market Size by Region: 2016 Versus 2021 Versus 2027
2 Oral Vaccines Market Competition by Manufacturers
2.1 Global Oral Vaccines Sales Market Share by Manufacturers (2016-2021)
2.2 Global Oral Vaccines Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Oral Vaccines Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Oral Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Oral Vaccines Market Competitive Situation and Trends
2.5.1 Oral Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Oral Vaccines Players Market Share by Revenue
2.5.3 Global Oral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Vaccines Retrospective Market Scenario by Region
3.1 Global Oral Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Oral Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Oral Vaccines Market Facts & Figures by Country
3.3.1 North America Oral Vaccines Sales by Country
3.3.2 North America Oral Vaccines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Oral Vaccines Market Facts & Figures by Country
3.4.1 Europe Oral Vaccines Sales by Country
3.4.2 Europe Oral Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Oral Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Oral Vaccines Sales by Region
3.5.2 Asia Pacific Oral Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Oral Vaccines Market Facts & Figures by Country
3.6.1 Latin America Oral Vaccines Sales by Country
3.6.2 Latin America Oral Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Oral Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Oral Vaccines Sales by Country
3.7.2 Middle East and Africa Oral Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Oral Vaccines Historic Market Analysis by Type
4.1 Global Oral Vaccines Sales Market Share by Type (2016-2021)
4.2 Global Oral Vaccines Revenue Market Share by Type (2016-2021)
4.3 Global Oral Vaccines Price by Type (2016-2021)
5 Global Oral Vaccines Historic Market Analysis by Application
5.1 Global Oral Vaccines Sales Market Share by Application (2016-2021)
5.2 Global Oral Vaccines Revenue Market Share by Application (2016-2021)
5.3 Global Oral Vaccines Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Merck Oral Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GSK Oral Vaccines Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Sanofi Oral Vaccines Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Lanzhou Institute
6.4.1 Lanzhou Institute Corporation Information
6.4.2 Lanzhou Institute Description and Business Overview
6.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Lanzhou Institute Oral Vaccines Product Portfolio
6.4.5 Lanzhou Institute Recent Developments/Updates
6.5 Serum Institute
6.5.1 Serum Institute Corporation Information
6.5.2 Serum Institute Description and Business Overview
6.5.3 Serum Institute Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Serum Institute Oral Vaccines Product Portfolio
6.5.5 Serum Institute Recent Developments/Updates
6.6 Valneva
6.6.1 Valneva Corporation Information
6.6.2 Valneva Description and Business Overview
6.6.3 Valneva Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Valneva Oral Vaccines Product Portfolio
6.6.5 Valneva Recent Developments/Updates
6.7 Shanghai United Cell
6.6.1 Shanghai United Cell Corporation Information
6.6.2 Shanghai United Cell Description and Business Overview
6.6.3 Shanghai United Cell Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Shanghai United Cell Oral Vaccines Product Portfolio
6.7.5 Shanghai United Cell Recent Developments/Updates
6.8 Bibcol
6.8.1 Bibcol Corporation Information
6.8.2 Bibcol Description and Business Overview
6.8.3 Bibcol Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Bibcol Oral Vaccines Product Portfolio
6.8.5 Bibcol Recent Developments/Updates
6.9 PaxVax
6.9.1 PaxVax Corporation Information
6.9.2 PaxVax Description and Business Overview
6.9.3 PaxVax Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.9.4 PaxVax Oral Vaccines Product Portfolio
6.9.5 PaxVax Recent Developments/Updates
6.10 Vabiotech
6.10.1 Vabiotech Corporation Information
6.10.2 Vabiotech Description and Business Overview
6.10.3 Vabiotech Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Vabiotech Oral Vaccines Product Portfolio
6.10.5 Vabiotech Recent Developments/Updates
6.11 Tiantan Biological
6.11.1 Tiantan Biological Corporation Information
6.11.2 Tiantan Biological Oral Vaccines Description and Business Overview
6.11.3 Tiantan Biological Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Tiantan Biological Oral Vaccines Product Portfolio
6.11.5 Tiantan Biological Recent Developments/Updates
6.12 EuBiologics
6.12.1 EuBiologics Corporation Information
6.12.2 EuBiologics Oral Vaccines Description and Business Overview
6.12.3 EuBiologics Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.12.4 EuBiologics Oral Vaccines Product Portfolio
6.12.5 EuBiologics Recent Developments/Updates
6.13 Panacea Biotec Ltd
6.13.1 Panacea Biotec Ltd Corporation Information
6.13.2 Panacea Biotec Ltd Oral Vaccines Description and Business Overview
6.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Panacea Biotec Ltd Oral Vaccines Product Portfolio
6.13.5 Panacea Biotec Ltd Recent Developments/Updates
6.14 Bio-Med
6.14.1 Bio-Med Corporation Information
6.14.2 Bio-Med Oral Vaccines Description and Business Overview
6.14.3 Bio-Med Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Bio-Med Oral Vaccines Product Portfolio
6.14.5 Bio-Med Recent Developments/Updates
6.15 Halfkin Bio-Pharmaceuticals
6.15.1 Halfkin Bio-Pharmaceuticals Corporation Information
6.15.2 Halfkin Bio-Pharmaceuticals Oral Vaccines Description and Business Overview
6.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio
6.15.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7 Oral Vaccines Manufacturing Cost Analysis
7.1 Oral Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Oral Vaccines
7.4 Oral Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Oral Vaccines Distributors List
8.3 Oral Vaccines Customers
9 Oral Vaccines Market Dynamics
9.1 Oral Vaccines Industry Trends
9.2 Oral Vaccines Growth Drivers
9.3 Oral Vaccines Market Challenges
9.4 Oral Vaccines Market Restraints
10 Global Market Forecast
10.1 Oral Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Oral Vaccines by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Oral Vaccines by Type (2022-2027)
10.2 Oral Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Oral Vaccines by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Oral Vaccines by Application (2022-2027)
10.3 Oral Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Oral Vaccines by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Oral Vaccines by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Oral Vaccines Sales (M Doses) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Oral Vaccines Sales (M Doses) Comparison by Application (2021-2027)
Table 3. Global Oral Vaccines Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Oral Vaccines Covered in This Study
Table 5. Global Oral Vaccines Sales (M Doses) of Key Manufacturers (2016-2021)
Table 6. Global Oral Vaccines Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Oral Vaccines Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Oral Vaccines Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Oral Vaccines Average Price (USD/K Doses) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Oral Vaccines Manufacturing Sites and Area Served
Table 11. Manufacturers Oral Vaccines Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Oral Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Vaccines as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Oral Vaccines Sales by Region (2016-2021) & (M Doses)
Table 16. Global Oral Vaccines Sales Market Share by Region (2016-2021)
Table 17. Global Oral Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Oral Vaccines Sales by Country (2016-2021) & (M Doses)
Table 19. North America Oral Vaccines Sales Market Share by Country (2016-2021)
Table 20. North America Oral Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Oral Vaccines Revenue Market Share by Country (2016-2021)
Table 22. Europe Oral Vaccines Sales by Country (2016-2021) & (M Doses)
Table 23. Europe Oral Vaccines Sales Market Share by Country (2016-2021)
Table 24. Europe Oral Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Oral Vaccines Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Oral Vaccines Sales by Region (2016-2021) & (M Doses)
Table 27. Asia Pacific Oral Vaccines Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Oral Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Oral Vaccines Revenue Market Share by Region (2016-2021)
Table 30. Latin America Oral Vaccines Sales by Country (2016-2021) & (M Doses)
Table 31. Latin America Oral Vaccines Sales Market Share by Country (2016-2021)
Table 32. Latin America Oral Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Oral Vaccines Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Oral Vaccines Sales by Country (2016-2021) & (M Doses)
Table 35. Middle East and Africa Oral Vaccines Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Oral Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Oral Vaccines Revenue Market Share by Country (2016-2021)
Table 38. Global Oral Vaccines Sales (M Doses) by Type (2016-2021)
Table 39. Global Oral Vaccines Sales Market Share by Type (2016-2021)
Table 40. Global Oral Vaccines Revenue (Million US$) by Type (2016-2021)
Table 41. Global Oral Vaccines Revenue Share by Type (2016-2021)
Table 42. Global Oral Vaccines Price (USD/K Doses) by Type (2016-2021)
Table 43. Global Oral Vaccines Sales (M Doses) by Application (2016-2021)
Table 44. Global Oral Vaccines Sales Market Share by Application (2016-2021)
Table 45. Global Oral Vaccines Revenue (Million US$) by Application (2016-2021)
Table 46. Global Oral Vaccines Revenue Share by Application (2016-2021)
Table 47. Global Oral Vaccines Price (USD/K Doses) by Application (2016-2021)
Table 48. Merck Corporation Information
Table 49. Merck Description and Business Overview
Table 50. Merck Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 51. Merck Oral Vaccines Product
Table 52. Merck Recent Developments/Updates
Table 53. GSK Corporation Information
Table 54. GSK Description and Business Overview
Table 55. GSK Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 56. GSK Oral Vaccines Product
Table 57. GSK Recent Developments/Updates
Table 58. Sanofi Corporation Information
Table 59. Sanofi Description and Business Overview
Table 60. Sanofi Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 61. Sanofi Oral Vaccines Product
Table 62. Sanofi Recent Developments/Updates
Table 63. Lanzhou Institute Corporation Information
Table 64. Lanzhou Institute Description and Business Overview
Table 65. Lanzhou Institute Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 66. Lanzhou Institute Oral Vaccines Product
Table 67. Lanzhou Institute Recent Developments/Updates
Table 68. Serum Institute Corporation Information
Table 69. Serum Institute Description and Business Overview
Table 70. Serum Institute Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 71. Serum Institute Oral Vaccines Product
Table 72. Serum Institute Recent Developments/Updates
Table 73. Valneva Corporation Information
Table 74. Valneva Description and Business Overview
Table 75. Valneva Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 76. Valneva Oral Vaccines Product
Table 77. Valneva Recent Developments/Updates
Table 78. Shanghai United Cell Corporation Information
Table 79. Shanghai United Cell Description and Business Overview
Table 80. Shanghai United Cell Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 81. Shanghai United Cell Oral Vaccines Product
Table 82. Shanghai United Cell Recent Developments/Updates
Table 83. Bibcol Corporation Information
Table 84. Bibcol Description and Business Overview
Table 85. Bibcol Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 86. Bibcol Oral Vaccines Product
Table 87. Bibcol Recent Developments/Updates
Table 88. PaxVax Corporation Information
Table 89. PaxVax Description and Business Overview
Table 90. PaxVax Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 91. PaxVax Oral Vaccines Product
Table 92. PaxVax Recent Developments/Updates
Table 93. Vabiotech Corporation Information
Table 94. Vabiotech Description and Business Overview
Table 95. Vabiotech Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 96. Vabiotech Oral Vaccines Product
Table 97. Vabiotech Recent Developments/Updates
Table 98. Tiantan Biological Corporation Information
Table 99. Tiantan Biological Description and Business Overview
Table 100. Tiantan Biological Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 101. Tiantan Biological Oral Vaccines Product
Table 102. Tiantan Biological Recent Developments/Updates
Table 103. EuBiologics Corporation Information
Table 104. EuBiologics Description and Business Overview
Table 105. EuBiologics Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 106. EuBiologics Oral Vaccines Product
Table 107. EuBiologics Recent Developments/Updates
Table 108. Panacea Biotec Ltd Corporation Information
Table 109. Panacea Biotec Ltd Description and Business Overview
Table 110. Panacea Biotec Ltd Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 111. Panacea Biotec Ltd Oral Vaccines Product
Table 112. Panacea Biotec Ltd Recent Developments/Updates
Table 113. Bio-Med Corporation Information
Table 114. Bio-Med Description and Business Overview
Table 115. Bio-Med Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 116. Bio-Med Oral Vaccines Product
Table 117. Bio-Med Recent Developments/Updates
Table 118. Halfkin Bio-Pharmaceuticals Corporation Information
Table 119. Halfkin Bio-Pharmaceuticals Description and Business Overview
Table 120. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 121. Halfkin Bio-Pharmaceuticals Oral Vaccines Product
Table 122. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 123. Production Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Oral Vaccines Distributors List
Table 126. Oral Vaccines Customers List
Table 127. Oral Vaccines Market Trends
Table 128. Oral Vaccines Growth Drivers
Table 129. Oral Vaccines Market Challenges
Table 130. Oral Vaccines Market Restraints
Table 131. Global Oral Vaccines Sales Forecast by Type (2022-2027) & (M Doses)
Table 132. Global Oral Vaccines Sales Market Share Forecast by Type (2022-2027)
Table 133. Global Oral Vaccines Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 134. Global Oral Vaccines Revenue Market Share Forecast by Type (2022-2027)
Table 135. Global Oral Vaccines Sales Forecast by Application (2022-2027) & (M Doses)
Table 136. Global Oral Vaccines Sales Market Share Forecast by Application (2022-2027)
Table 137. Global Oral Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 138. Global Oral Vaccines Revenue Market Share Forecast by Application (2022-2027)
Table 139. Global Oral Vaccines Sales Forecast by Region (2022-2027) & (M Doses)
Table 140. Global Oral Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 141. Global Oral Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 142. Global Oral Vaccines Revenue Market Share Forecast by Region (2022-2027)
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oral Vaccines
Figure 2. Global Oral Vaccines Market Share by Type in 2020 & 2027
Figure 3. Rotavirus Vaccine Product Picture
Figure 4. Cholera Vaccine Product Picture
Figure 5. Oral Polio Vaccine Product Picture
Figure 6. Global Oral Vaccines Market Share by Application in 2020 & 2027
Figure 7. Public
Figure 8. Private
Figure 9. Global Oral Vaccines Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Oral Vaccines Market Size 2016-2027 (US$ Million)
Figure 11. Global Oral Vaccines Sales 2016-2027 (M Doses)
Figure 12. Global Oral Vaccines Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Oral Vaccines Sales Share by Manufacturers in 2020
Figure 14. Global Oral Vaccines Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Oral Vaccines Players: Market Share by Revenue in 2020
Figure 16. Oral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Oral Vaccines Sales Market Share by Region (2016-2021)
Figure 18. Global Oral Vaccines Sales Market Share by Region in 2020
Figure 19. Global Oral Vaccines Revenue Market Share by Region (2016-2021)
Figure 20. Global Oral Vaccines Revenue Market Share by Region in 2020
Figure 21. U.S. Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. U.A.E Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Oral Vaccines by Type (2016-2021)
Figure 46. Sales Market Share of Oral Vaccines by Application (2016-2021)
Figure 47. Sales Market Share of Oral Vaccines by Application in 2020
Figure 48. Revenue Share of Oral Vaccines by Application (2016-2021)
Figure 49. Revenue Share of Oral Vaccines by Application in 2020
Figure 50. Manufacturing Cost Structure of Oral Vaccines
Figure 51. Manufacturing Process Analysis of Oral Vaccines
Figure 52. Oral Vaccines Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs